Rapport Therapeutics Management
Management criteria checks 1/4
Rapport Therapeutics' CEO is Abe Ceesay, appointed in Feb 2023, has a tenure of 1.75 years. total yearly compensation is $2.42M, comprised of 16.6% salary and 83.4% bonuses, including company stock and options. directly owns 2.16% of the company’s shares, worth $17.36M. The average tenure of the management team and the board of directors is 1.5 years and 1.3 years respectively.
Key information
Abe Ceesay
Chief executive officer
US$2.4m
Total compensation
| CEO salary percentage | 16.6% |
| CEO tenure | 1.8yrs |
| CEO ownership | 2.2% |
| Management average tenure | 1.5yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$72m |
| Jun 30 2024 | n/a | n/a | -US$63m |
| Mar 31 2024 | n/a | n/a | -US$51m |
| Dec 31 2023 | US$2m | US$400k | -US$35m |
Compensation vs Market: Abe's total compensation ($USD2.42M) is about average for companies of similar size in the US market ($USD3.21M).
Compensation vs Earnings: Insufficient data to compare Abe's compensation with company performance.
CEO
Abe Ceesay (46 yo)
1.8yrs
Tenure
US$2,415,840
Compensation
Mr. Abraham N. Ceesay, also known as Abe, MBA, serves as the Chief Executive Officer and President at Rapport Therapeutics, Inc. since February 2023 and serves as its Treasurer and serves as its Director s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Independent Chairman | 1.9yrs | US$568.99k | 1.31% $ 10.5m | |
| CEO, President | 1.8yrs | US$2.42m | 2.16% $ 17.4m | |
| Chief Financial Officer | less than a year | US$2.48m | no data | |
| Chief Operating Officer | 1.2yrs | US$1.78m | 0.43% $ 3.5m | |
| Founder & Chief Scientific Officer | 1.8yrs | no data | 1.31% $ 10.5m | |
| Chief Information Officer & Head of Operations | no data | no data | no data | |
| Head of Communications & Investor Relations | less than a year | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Chief Medical Officer | 1.8yrs | no data | 0.54% $ 4.3m | |
| Chief Development Officer | 1.8yrs | no data | 0.80% $ 6.4m | |
| Senior Vice President of Medical Affairs | no data | no data | no data | |
| Senior Vice President of CMC & Product Development | no data | no data | no data |
1.5yrs
Average Tenure
57yo
Average Age
Experienced Management: RAPP's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Independent Chairman | 1.9yrs | US$568.99k | 1.31% $ 10.5m | |
| CEO, President | 1.7yrs | US$2.42m | 2.16% $ 17.4m | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | 1.3yrs | no data | 0.24% $ 1.9m | |
| Director | no data | no data | no data | |
| Co-Chair of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 2.8yrs | US$400.23k | no data | |
| Co-Chair of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board & Director | 1.2yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
1.3yrs
Average Tenure
59.5yo
Average Age
Experienced Board: RAPP's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.